Search This Blog

Wednesday, August 7, 2019

Portola Pharmaceuticals EPS beats by $0.05, beats on revenue

Portola Pharmaceuticals (NASDAQ:PTLA): Q2 GAAP EPS of -$0.97 beats by $0.05.
Revenue of $28.4M (+608.2% Y/Y) beats by $2.98M.
Shares +1.3%.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)